The EMT transcription factor ZEB1 governs a fitness-promoting but vulnerable DNA replication stress response

  • Harald Schuhwerk*
  • , Julia Kleemann
  • , Pooja Gupta
  • , Ruthger van Roey
  • , Isabell Armstark
  • , Martina Kreileder
  • , Nora Feldker
  • , Vignesh Ramesh
  • , Yussuf Hajjaj
  • , Kathrin Fuchs
  • , Mousumi Mahapatro
  • , Mojca Hribersek
  • , Marco Volante
  • , Arwin Groenewoud
  • , Felix B. Engel
  • , Paolo Ceppi
  • , Markus Eckstein
  • , Arndt Hartmann
  • , Fabian Müller
  • , Torsten Kroll
  • Marc P. Stemmler, Simone Brabletz, Thomas Brabletz
*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

284 Downloads (Pure)

Abstract

The DNA damage response (DDR) and epithelial-to-mesenchymal transition (EMT) are two crucial cellular programs in cancer biology. While the DDR orchestrates cell-cycle progression, DNA repair, and cell death, EMT promotes invasiveness, cellular plasticity, and intratumor heterogeneity. Therapeutic targeting of EMT transcription factors, such as ZEB1, remains challenging, but tumor-promoting DDR alterations elicit specific vulnerabilities. Using multi-omics, inhibitors, and high-content microscopy, we discover a chemoresistant ZEB1-high-expressing sub-population (ZEB1hi) with co-rewired cell-cycle progression and proficient DDR across tumor entities. ZEB1 stimulates accelerated S-phase entry via CDK6, inflicting endogenous DNA replication stress. However, DDR buildups involving constitutive MRE11-dependent fork resection allow homeostatic cycling and enrichment of ZEB1hi cells during transforming growth factor β (TGF-β)-induced EMT and chemotherapy. Thus, ZEB1 promotes G1/S transition to launch a progressive DDR benefitting stress tolerance, which concurrently manifests a targetable vulnerability in chemoresistant ZEB1hi cells. Our study thus highlights the translationally relevant intercept of the DDR and EMT.

Original languageEnglish
Article number111819
JournalCell Reports
Volume41
Issue number11
ISSN2211-1247
DOIs
Publication statusPublished - 13. Dec 2022

Keywords

  • cancer
  • cell cycle
  • chemoresistance
  • CP: Cancer
  • DNA damage response
  • DNA replication stress
  • epithelial-to-mesenchymal transition
  • heterogeneity
  • MRE11
  • plasticity
  • ZEB1

Fingerprint

Dive into the research topics of 'The EMT transcription factor ZEB1 governs a fitness-promoting but vulnerable DNA replication stress response'. Together they form a unique fingerprint.

Cite this